NCM
SBIO icon

Northwest Capital Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Northwest Capital Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,400
Closed -$50K – 539
2024
Q1 		$50K Hold
1,400
– – 0.02% 220
2023
Q4 		$46.1K Hold
1,400
– – 0.02% 226
2023
Q3 		$38.1K Hold
1,400
– – 0.01% 226
2023
Q2 		$44.2K Buy
+1,400
New +$43.5K 0.02% 220

Other funds holding SBIO

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
PWA
Phoenix Wealth Advisors Chapel Hill, North Carolina $253M AUM 17.97% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northwest Capital Management's SBIO Position: Q2 2024 in Review

Northwest Capital Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2024, closing a stake of 1,400 shares — an estimated $50K sold.

Northwest Capital Management first reported a position in SBIO in Q2 2023 and held it in 4 quarters. The position peaked at $50K in Q1 2024. 38 funds tracked by Wall St. Rank hold SBIO as of Q2 2024.

  • Northwest Capital Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2024 after selling out during the quarter.
  • Northwest Capital Management sold 1,400 ALPS Medical Breakthroughs ETF shares in Q2 2024, an estimated $50K.
  • Northwest Capital Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2023 and held it in 4 quarters.
  • Northwest Capital Management's ALPS Medical Breakthroughs ETF position peaked at $50K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2024.

Based on Northwest Capital Management's 13F filing for Q2 2024, filed 9 Jul 2024.